Javascript must be enabled to continue!
Assessment of Intracellular Insulin Content during All Steps of Human Islet Isolation Procedure
View through CrossRef
This study investigated the recovery of pancreatic insulin content during human islet isolation prior to and after digestion-filtration, continuous Hanks-Ficoll gradient purification ( n = 20), and 3–4 day culture at 22°C ( n = 6). The native insulin content varied in a wide range from 28.4 U to 360.8 U/pancreas. After digestion the initially measured average insulin content of 115.8 ± 20.8 U/pancreas (mean ± SEM) increased to 264.6 ± 22.8% ( p < 0.001). This increase of insulin during pancreas digestion was attributed to the asymetrical distribution of insulin within the pancreas. Sampling of insulin within the pancreatic caput seemed not to be representative for the insulin content of the complete native organ, because the ratio of insulin per gram tissue within the pancreatic cauda compared to the caput ( n = 5) was 2.4 ± 0.4 ( p < 0.05). After purification total insulin recovery was 55.3 ± 4.8% ( p < 0.001). Because recovery of islet equivalent number (IEQ) (83.7 ± 4.4%) exceeded insulin recovery, insulin/IEQ ratio decreased from 656.8 ± 70.6 μU/IEQ before purification to 436.4 ± 58.1 μU/IEQ ( p < 0.001) after purification. After 22° C culture ( n = 6) recovery of insulin and IEQ was 80.1 ± 8.1% ( p < 0.05) and 92.8 ± 3.5% ( p = NS), respectively. Insulin content per IEQ decreased to 85.8 ± 6.5% ( p < 0.05). This study clearly shows that most of islet insulin is lost during purification. This seems to be caused rather by an amplified insulin release than by the loss of islets itself. This release may facilitate the separation of endocrine and exocrine tissue by gradient centrifugation, but may also accelerate islet exhaustion detrimental for long-term insulin independence. © 1998 Elsevier Science Inc.
Title: Assessment of Intracellular Insulin Content during All Steps of Human Islet Isolation Procedure
Description:
This study investigated the recovery of pancreatic insulin content during human islet isolation prior to and after digestion-filtration, continuous Hanks-Ficoll gradient purification ( n = 20), and 3–4 day culture at 22°C ( n = 6).
The native insulin content varied in a wide range from 28.
4 U to 360.
8 U/pancreas.
After digestion the initially measured average insulin content of 115.
8 ± 20.
8 U/pancreas (mean ± SEM) increased to 264.
6 ± 22.
8% ( p < 0.
001).
This increase of insulin during pancreas digestion was attributed to the asymetrical distribution of insulin within the pancreas.
Sampling of insulin within the pancreatic caput seemed not to be representative for the insulin content of the complete native organ, because the ratio of insulin per gram tissue within the pancreatic cauda compared to the caput ( n = 5) was 2.
4 ± 0.
4 ( p < 0.
05).
After purification total insulin recovery was 55.
3 ± 4.
8% ( p < 0.
001).
Because recovery of islet equivalent number (IEQ) (83.
7 ± 4.
4%) exceeded insulin recovery, insulin/IEQ ratio decreased from 656.
8 ± 70.
6 μU/IEQ before purification to 436.
4 ± 58.
1 μU/IEQ ( p < 0.
001) after purification.
After 22° C culture ( n = 6) recovery of insulin and IEQ was 80.
1 ± 8.
1% ( p < 0.
05) and 92.
8 ± 3.
5% ( p = NS), respectively.
Insulin content per IEQ decreased to 85.
8 ± 6.
5% ( p < 0.
05).
This study clearly shows that most of islet insulin is lost during purification.
This seems to be caused rather by an amplified insulin release than by the loss of islets itself.
This release may facilitate the separation of endocrine and exocrine tissue by gradient centrifugation, but may also accelerate islet exhaustion detrimental for long-term insulin independence.
© 1998 Elsevier Science Inc.
Related Results
Progressive Islet Graft Failure Occurs Significantly Earlier in Autoantibody-Positive Than in Autoantibody-Negative IDDM Recipients of Intrahepatic Islet Allografts
Progressive Islet Graft Failure Occurs Significantly Earlier in Autoantibody-Positive Than in Autoantibody-Negative IDDM Recipients of Intrahepatic Islet Allografts
Alloimmunity has been uncovered to be a cause of graft loss representing a major barrier for clinical islet transplantation, and several studies are designed to evaluate new strate...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
Abstract 15122: Il18 Uses Both Il18 Receptor and Na-cl Co-transporter to Support Islet β Cell Proliferation and Insulin Secretion
Abstract 15122: Il18 Uses Both Il18 Receptor and Na-cl Co-transporter to Support Islet β Cell Proliferation and Insulin Secretion
Introduction:
The regeneration of pancreatic β cells to restore insulin production is a promising therapeutic strategy for insulin-dependent type-1 (T1D) and type-2 dia...
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
Abstract
Abstract 4908
Insulin resistance can be a major problem in patients with diabetes mellitus. Although multiple reasons can result in this prob...
Improving Pancreatic Islet Transplantation Using Fibrin Hydrogel Containing Microvascular Fragments in Subcutaneous Tissue of Type I Diabetic Rats
Improving Pancreatic Islet Transplantation Using Fibrin Hydrogel Containing Microvascular Fragments in Subcutaneous Tissue of Type I Diabetic Rats
Abstract
Objective(s): Islet transplantation offers a promising treatment for Type 1 diabetes mellitus (T1DM). Subcutaneous tissue is a non-invasive site, but it has poor b...
Exosomal-microRNAs Improve Islet Cell Survival and Function In Islet
Transplantation
Exosomal-microRNAs Improve Islet Cell Survival and Function In Islet
Transplantation
Abstract:
Exosomal-microRNAs (Exo-miRNAs) are key regulators of islet cell function, including insulin
expression, processing, and secretion. Exo-miRNAs have a significant impact o...
Short-term CFTR inhibition reduces islet area in C57BL/6 mice
Short-term CFTR inhibition reduces islet area in C57BL/6 mice
AbstractCystic fibrosis-related diabetes (CFRD) worsens CF lung disease leading to early mortality. Loss of beta cell area, even without overt diabetes or pancreatitis is consisten...
Current Assessment of Clinical Pancreatic Islet Allotransplantation
Current Assessment of Clinical Pancreatic Islet Allotransplantation
Clinical islet allotransplantation represents a minimally invasive, efficacious alternative to pancreas transplantation for restoring glycemic control and insulin independence in s...


